← Back

Ningxia Xinri Hengli Steel Wire Rope Co Ltd

Ningxia Zhongke Biotechnology Co., Ltd. produces and sells coal-based activated carbon and lauric acid products. It also offers long-chain dicarboxylic acid and nutritional additives. The company was founded in 1998 and is based in Shizuishan, China.

Country
Sector
Price · split & dividend adjusted
News & notes moving 600165.CG
600165.CG

Ningke Bio reports net loss of 132 million yuan in 2026 interim report

Ningke Bio released its 2026 interim report, showing total operating revenue of 274 million yuan and a net loss attributable to the parent company of 132 million yuan. Net cash flow from operating activities was negative 203 million yuan, a decrease of 14.5 million yuan compared with the same period last year. The company's asset-liability ratio was 48.59 percent, gross margin was negative 6.02 percent, return on equity was negative 12.32 percent, and diluted earnings per share was negative 0.08 yuan. The number of shareholders was 16,700, and the top ten shareholders held 52.04 percent of the total share capital.
Jiemian·21dRead more →
600165.CG

ST Ningke Applies to Remove Other Risk Warning

ST Ningke announced that the circumstances triggering the other risk warning on its shares have been resolved, and the conditions for applying to remove the other risk warning have been met. The company has submitted the removal application to the Shanghai Stock Exchange, which will decide whether to approve the removal within 15 trading days of receiving the application.
证券时报·35dRead more →
600165.CG3

ST Ningke Directors and All Senior Executives Plan to Increase Shareholdings, Total Amount Between 3.7 Million and 6 Million Yuan

ST Ningke announced that some directors and all senior executives plan to increase their shareholdings in the company within six months from the date of the announcement, through centralized bidding. The total increase amount will be no less than 3.7 million yuan and no more than 6 million yuan. The participants include Chairman and General Manager Fu Jie, Director Feng Zhansheng, Director, Deputy General Manager and Board Secretary Wang Wei, Deputy General Manager Li Zhongfu, Deputy General Manager Qu Xiaochun, and Chief Financial Officer Jin Xiangyu. None of them directly held company shares before the increase. This share increase does not set a price range, and the funds will come from their own or self-raised capital.
为自有或自筹资金·57dRead more →